CLINICAL_TRIALS
trial_result
· 2019-11-04
Clinical Trial Update: A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval [Phase 1]
Summary
Phase 1 study evaluating NST-4016 effects on QT/QTc in dyslipidemia patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NorthSea Therapeutics B.V. | Conditions: Dyslipidemias | Phase 1 | Status: COMPLETED | Results posted: 2019-11-04